The news is directly about Staar Surgical and is likely to impact its stock. While the 'Buy' rating is maintained, the lowered price target may cause some investors to reassess their positions, potentially leading to short-term volatility. However, the overall impact is neutral as the 'Buy' rating indicates continued confidence in the company.